Abstracts tagged "Osteoarthritis and steroids"

Abstract Number: 443 • 2018 ACR/ARHP Annual Meeting
Impact of Intra-Articular Steroid Injection on Bone Marrow Lesions in Osteoarthritis of the Hip: An Assessment Using the Outcome Measures in Rheumatology Hip MRI Inflammation Scoring System
Walter P. Maksymowych^1,2, Robert G. Lambert³, Marcus Pianta⁴, Zeid Al-Ani⁵, Duncan Lindsay⁵, Ulrich Weber⁶, Susanne J Pedersen⁷, Stephanie Wichuk⁸, Kieran Steer⁹, Geoffrey Bostick¹⁰, Joel Paschke¹ and Jacob L. Jaremko¹¹, ¹CaRE Arthritis, Edmonton, AB, Canada, ²Medicine, Medicine, University of Alberta, Edmonton, AB, Canada, ³Department of Radiology & Diagnostic Imaging, University of Alberta, Edmonton, AB, Canada, ⁴Rheumatology, St. Vincent's Hospital, Melbourne, Australia, ⁵Radiology & Diagnostic Imaging, University of Alberta, Edmonton, AB, Canada, ⁶Department of Research, King Christian 10th Hospital for Rheumatic Diseases, Graasten, Denmark, ⁷Rheumatology, Gentofte Hospital, Copenhagen, Denmark, ⁸University of Alberta, Edmonton, AB, Canada, ⁹Department of Radiology and Diagnostic Imaging, University of Alberta, Edmonton, AB, Canada, ¹⁰Radiology and Diagnostic Imaging, University of Alberta, Edmonton, AB, Canada, ¹¹Radiology, University of Alberta, Edmonton, AB, Canada
Background/Purpose: Intra-articular (I/A) steroid injection is an effective treatment for alleviating symptoms in osteoarthritis (OA) of the hip but the impact of this treatment on…
Abstract Number: 2242 • 2014 ACR/ARHP Annual Meeting
Effects of Intraarticular (IA) Corticosteroid Injections on Bone Markers and Endogenous Cortisol in Patients with Knee Osteoarthritis (OA): A Randomized, Double-Blind, Placebo Controlled Trial
Muhammad Imran¹, Aruna Baratham², Jo Wick³, Barbara Lukert⁴ and Herbert Lindsley⁵, ¹Rheumatology, University of Kansas Medical Center, Kansas City, KS, ²Rheumatology, Allergy and Immunology, Private Community Practice, Kansas city, KS, ³Biostatistics, Kansas University Med Ctr, Kansas City, KS, ⁴Internal Medicine, Kansas University Medical Center, kansas city, KS, ⁵Rheumatology, Kansas University Med Ctr, Kansas City, KS
Background/Purpose: IA steroids are used to treat knee OA. Little is known about the systemic effect of intraarticular steroid injections on bone or the hypothalamic-pituitary-…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].